Watch past educational presentations and see live events in real time
Reference our medication guides for helpful information
Explore available award and grant opportunities for fellows-in-training.
Make a choice that matters
The best care starts with the best information. See videos to help answer your questions.
The ACR is accepting applications for mini curriculums, which are educational activities or curriculums to enhance the ACR Core Curriculum Outline.
The ACR Committee on Training and Workforce is pleased to present the Virtual Rheumatology Learning Collaborative (ViRL). This free 8-week lecture series started on April 6, 2020, and will continue through May 29, 2020.
This program is designed for educational purposes only. The material presented is not intended to represent the only or the best methods appropriate for the medical situations discussed, but rather is intended to present the opinions of the authors or presenters, which may be helpful to other practitioners. Attendees participating in this education activity sponsored by the ACR do so with full knowledge that they waive any claim they may have against the ACR for reliance on any information presented during this educational activity.
In this presentation, James Rosenbaum, MD, discusses adult inflammatory eye disease, eye disease in rheumatoid arthritis and systemic lupus, the relationship between acute anterior uveitis and spondyloarthritis, and the approach to a patient with orbital inflammation.
In this presentation, Rachel Wolfe, MD, discusses the use of prophylaxis and the impact on the rheumatology population.
In this lecture, Ted Mikuls, MD, MSPH, focuses on the epidemiology and burden posed by rheumatoid arthritis, with a focus on extra-articular disease. Topics covered include genetic and environmental risk factors for RA, the pre-clinical disease course, patterns of disease onset, and outcomes, particularly as they relate to extra-articular manifestations.
It could be argued our understanding of the mechanism by which ACPA induce disease has not kept pace with its therapy. For example, what do we actually know about where or how ACPA cause rheumatoid arthritis? What do we actually know about the penetrance of the genetic risk for rheumatoid arthritis? What do we actually know about the ability to eliminate ACPA? View the ViRL lecture from William Rigby, MD.
In this presentation, John Reveille, MD, reviews axial spondyloarthritis relative to classification criteria, genetics, clinical features, the progression from non-radiographic axial spondyloarthritis to ankylosing spondylitis, and treatment.
Building on the excellent talk on RA therapeutics from Michael Weinblatt, MD, James O'Dell, MD, highlights the optimal use of MTX, combination DMARD therapy, and niches for all currently used DMARDs. In this lecture, the emphasis is placed on using all the available DMARDs optimally for individual patients.
Please take a brief moment to answer a few questions regarding the ViRL lecture series. Your feedback will be used in evaluating and planning future programs.
The ACR would like to thank the lecturers who have donated their time and expertise to providing these lectures and to the following institutions that supported the effort and were instrumental in making it come to fruition:
Beth Israel Deaconess Medical Center
Brigham and Women's Hospital
Dartmouth – Hitchcock Medical Center
Children's National Medical Center
Johns Hopkins University
Loma Linda University
Massachusetts General Hospital
Medical University of South Carolina
Oregon Health and Science University
Rush Medical Center
University of California – Irvine
University of California – San Francisco
University of Chicago
University of Nebraska
University of North Carolina
University of Texas, Houston
University of Colorado
University of Rochester
Wake Forest Medical Center